AULBREY DE ALWIS: Open Payments
NPI 1427419233 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 17 payments from 8 companies in 2025. Trend: 2023 $15 · 2024 $377 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $182 |
| JAZZ PHARMACEUTICALS INC. | 2 | $76 |
| GlaxoSmithKline, LLC. | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| GENZYME CORPORATION | 2 | $50 |
| Amgen Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Liquidia Technologies, Inc. | 1 | $26 |
Products named: BREZTRI, DUPIXENT, XYWAV, AIRSUPRA, TRELEGY ELLIPTA, TEZSPIRE, Sunosi, YUTREPIA.
Industry payments across IL — which companies pay providers there.
